EGFR and cancer: However, we noticed that AREG elimination from PSC27 markedly dampened pathway activation induced by the full‐blown SASP of damaged stromal cells, suggesting AREG as a critical paracrine SASP factor that phosphorylates EGFR and engages multiple key intercellular signaling molecules in recipient cancer cells (Figure S3j).